<SEC-DOCUMENT>0001193125-17-197124-index.html : 20170607
<SEC-HEADER>0001193125-17-197124.hdr.sgml : 20170607
<ACCEPTANCE-DATETIME>20170607164859
ACCESSION NUMBER:		0001193125-17-197124
CONFORMED SUBMISSION TYPE:	424B2
PUBLIC DOCUMENT COUNT:		2
FILED AS OF DATE:		20170607
DATE AS OF CHANGE:		20170607

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			CTI BIOPHARMA CORP
		CENTRAL INDEX KEY:			0000891293
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				911533912
		STATE OF INCORPORATION:			WA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		424B2
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-200452
		FILM NUMBER:		17897747

	BUSINESS ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121
		BUSINESS PHONE:		2062827100

	MAIL ADDRESS:	
		STREET 1:		3101 WESTERN AVENUE
		STREET 2:		SUITE 600
		CITY:			SEATTLE
		STATE:			WA
		ZIP:			98121

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	CELL THERAPEUTICS INC
		DATE OF NAME CHANGE:	19960321
</SEC-HEADER>
<DOCUMENT>
<TYPE>424B2
<SEQUENCE>1
<FILENAME>d404406d424b2.htm
<DESCRIPTION>424B2
<TEXT>
Document 1 - file: d404406d424b2.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>g404406g61r59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
Document 2 - file: g404406g61r59.jpg

</DOCUMENT>
</SEC-DOCUMENT>